Publications found:
251,903
Sort by:
Indian Diagnostic Market Analysis
US$ 800.00
Single User PDF Format: US$ 800.00 Multi-User License: US$ 1400.00 Hard Copy: US$ 1000.00 CD-ROM: US$ 1000.00Indian diagnostics sector is witnessing an era of immense progress in innovative competenc...
June 2011
65 pages
Global Obesity Drug Market Analysis
US$ 1,000.00
Single User PDF Format: US$ 1,000.00 Multi-User License: US$ 1,500.00 Hard Copy: US$ 1,100.00 CD-ROM: US$ 1,100.00 The obesity epidemic has been disseminating among developed countries as well as low...
June 2011
85 pages
Israel Life Sciences Market Analysis
US$ 800.00
Single User PDF Format: US$ 800.00 Multi-User License: US$ 1,500.00 Hard Copy: US$ 900.00 CD-ROM: US$ 900.00 The field of life sciences has stipulated itself as one of the major businesses in Israel....
June 2011
55 pages
MSL-KOL Engagement: Ensuring Compliance
US$ 495.00
After its initial function to build rapport with KOLs, the MSL role has evolved from being a support to sales reps to the forefront of pharmaceutical practice. Lode Dewulf, chief medical affairs offic...
June 2011
47 pages
Pharma on Twitter: Developing a Presence
US$ 395.00
Does your company have a Twitter account? Want to know what all the buzz is about? Whether you are an experienced Twitter user or just curious, Pharma on Twitter: Developing a Presence, shares first-h...
June 2011
56 pages
European Markets for Cosmetic Surgery, Facial Aesthetics and Medical Laser Devices 2011
US$ 11,495.00
The combined European cosmetic surgery, facial aesthetics and medical laser device market was valued at over €657 million in 2010. This market ... market drivers and limiters and a detailed competitive analysis, including manufacturer market shares and product portfolios. This is an executive summary only. The ...
June 2011
287 pages
European Markets for Cardiac Surgery Devices
US$ 11,495.00
... countries covered in this report include: Germany France U.K Italy Spain Benelux Scandinavia Portugal Austria Switzerland Within the European cardiac surgery device market, companies such as Edwards Lifesciences, Maquet, Medtronic, Sorin and St. Jude lead the market, among many others. This ...
June 2011
530 pages
European Markets for Hearing Aids and Audiology Devices 2011
US$ 11,495.00
... models. In addition, the European market for hearing devices exhibits high market potential as the penetration of hearing aid users in Europe is only 18.5%. Growth ... innovations that are offered by the manufacturers and the distribution of hearing aids by the retailers to the end users. This report includes a ...
June 2011
553 pages
What Consumers Want – Buying Trends in European Home Care
US$ 2,000.00
... consumer purchasing patterns today and in the future. Euromonitor International's What Consumers Want – Buying Trends in European Home Care global briefing offers an ... and forecasts), company shares, brand shares and distribution data. Why buy this report? Get a detailed picture of the Home Care market; ...
June 2011
43 pages
Molecular Diagnostics Market Report: 2011 Edition
US$ 800.00
... , QIAGEN, Bayer, Abbott, and Becton Dickinson. The current report analyzes the molecular diagnostic market on the global basis. It also presents a view of the various ...
June 2011
43 pages
Global Wound Care Market Report: 2011 Edition
US$ 700.00
... reliability, price, and global reach, among such other factors. The report offers an analysis of the global wound care market. It also discusses key market trends, growth drivers ...
June 2011
34 pages
Competitor Analysis: Ras-Raf-MEK-ERK Inhibitors
US$ 660.00
... other pathywas such as the PI3K-Akt-mTOR pathways. Combining a mutant B-Raf inhibitor with a targeted T-cell antibody, such as ipilimumab, may increase ... ERK Pathway Corporate Ras-Raf-MEK-ERK Inhibitor R&D Pipelines About La Merie About Competitor Analysis Series: The Competitor Analysis Series delivers ...
June 2011
75 pages
Analyzing the Major Pharmaceutical Markets
US$ 300.00
... the knowledge employment ratios globally. Aruvian's R'search’s report – Analyzing the Major Pharmaceutical Markets - globally is a complete ready country reckoner which offers the analyst ...
June 2011
100 pages
Looking at Offshoring in the Pharmaceutical Industry
US$ 300.00
... expand their global pharmaceutical revenues. Aruvian's R'search’s report – Looking at Offshoring in the Pharmaceutical Industry - is a detailed analysis of the ... employment scenarios in emerging and growing economies. The impact of Offshoring as a practice cannot be understood without a complete study of ...
June 2011
50 pages
Looking at the Cancer Therapy Market
US$ 200.00
... presents a comprehensive research report – Looking at the Cancer Therapy Market – which analyzes the global cancer market. Explaining the basics of cancer, to the treatments available and ...
June 2011
60 pages
Competitor Analysis: Hepatitis Vaccines
US$ 498.00
... Vaccines Combination Vaccines including HAV Vaccines Combination Vaccines including HBV Vaccines Hepatitis C Virus Vaccines Hepatitis E Virus Vaccines Corporate Hepatitis Vaccine Product Portfolios and R&D Pipelines About Competitor Analysis Series: The Competitor Analysis Series delivers NO-FRILLS, but ...
June 2011
96 pages
Competitor Analysis: PI3K-AKT-mTOR Inhibitors
US$ 711.00
... effort has gone into developing agents that inhibit one or more PI3K isoforms, e.g. alpha and beta, as well as closely related proteins implicated in ... Others Corporate PI3K-AKT-mTOR Inhibitor R&D Pipelines About La Merie About Competitor Analysis Series: The Competitor Analysis Series delivers NO-FRILLS, ...
June 2011
100 pages
Competitor Analysis: IGF-1R Antagonists
US$ 275.00
... -1/R antagonists Small Molecule Multi-target IGF-1/R antagonists Biologics as Selective IGF-1/R antagonists Biologics as Dual IGF-1/R antagonists Corporate IGF-1R Antagonist R&D Pipelines About La Merie About Competitor Analysis Series: The Competitor Analysis Series delivers NO-FRILLS, but concise ...
June 2011
26 pages
INTERCELL - No Tangible Value!
US$ 90.00
... on sideline, as there is no catalyst in 2011-12 that could boost the stock. Intercell (ICLL) woes of 2010 became worse in 2011 chiefly due to the ...
June 2011
1 pages
Catalysts Driven Investment Opportunities
US$ 140.00
... ) in the Biotech sector. The table lists the drug related catalysts for the Rising Star or Mature Biotech companies, our expectations ... of the series, which we will keep releasing in a timely manner. The catalysts include outcome of Advisory Committee Meetings (only June), PDUFA dates ...
June 2011
4 pages
Dr Reddy's PARA IV Pipeline Analysis
US$ 350.00
Dr Reddys has pipeline of ~20 Para IVs having branded sales of ~$24b. Among its Para IV pipeline the confirmed opportunities (branded sales ~$11.2b) are Exelon, Propecia, Zyprexa (20 mg), ... Nexium, Lipitor and Geodon. We expect PAT of ~$185m from the Dr. Reddy’s Para IVs which is ~3% of the current market Cap.
June 2011
21 pages
Lupin's PARA IV Pipeline Analysis
US$ 350.00
Lupin has pipeline of ~34 products having branded sales of ~$16b. Among its Para IV pipeline most lucrative opportunities are very few like that of Geodon, ... and Asacol. On other hand there are some Para IVs ...
June 2011
28 pages
Para IV presentation
US$ 350.00
A macro study on Indian Pharma Para IV litigations – a part of our recently introduced web based application - PARA IV Plus™ . This will provide you with a broad but meaningful insight to the prevalence of Indian Pharmaceutical companies in the Para IV space
June 2011
9 pages
RANBAXY'S PARA IV PIPELINE ANALYSIS
US$ 350.00
Ranbaxy has a pipeline of ~19 Para IV challenges, of which 12 are FTF’s. The total branded sales of these drugs under Para IV challenge by Ranbaxy is approximately $25b. Most of these Para ... offer decent upside. We expect Ranbaxy to generate a cumulative PAT of ~$950m from these Para IV opportunities, which is ...
June 2011
22 pages
Tarcva - EURTAC Data positive: Threat to Iressa in Firstline NSCLC
US$ 140.00
... by 63 % compared to chemotherapy (9.7 m vs 5.2 m). Interim analysis of EURTAC trial showed that Tarceva improved the overall survival by 4 m (22.9 m ... vs 18.8 m) compared to cisplatin chemotherapy. The data poses threat to AZN’s Iressa as it has not demonstrated OS ... lines of EGFR positive advanced NSCLC.
June 2011
2 pages
Emerging Pharmaceutical Markets 2012
US$ 3,907.00
... to strong performance in the emerging pharmaceutical markets, the global pharmaceutical market is expected to reach US$ 1,020 Billion by the end of 2012. This research ... therapeutic segments, different and complex regulatory law and a fragmented market. The worldwide economic crisis has also added a new layer ...
May 2011
222 pages
Umbilical Cord Blood Banking Market Trends 2011
US$ 1,323.00
... , utilization trends of cord blood for different diseases in different countries of the world. This report analyzes the umbilical cord blood marketplace ... and associated qualitative trends. This data-driven characterization of the cord blood banking market landscape is a hands-on document that can be used for ...
May 2011
42 pages
DISHMAN - Back To Basics
US$ 90.00
We reiterate our Underperform rating on Dishman despite it’s higher than expected Q4 FY11 result. The result was ...
May 2011
5 pages
Lupin Looses Combivir – A Big Blow To An Already Weak FY12 Pipeline
US$ 140.00
... for generic Combivir (Lamivudine + Zidovudine). With this approval, Teva has been granted and Lupin has ... ), Teva will launch its generic in Q4CY11. Lupin will be able to enter only after the 180 ... all other generics as well. We reiterate our Underperform on Lupin with target price of Rs.360 on the back of (1) ...
May 2011
2 pages
Clinical Trials Market in Russia
US$ 1,000.00
Single User PDF Format: US$ 1,000.00
Multi-User License: US$ 1,600.00
Hard Copy: US$ 1,200.00
CD-ROM: US$ 1,200.00 The clinical trials market in Russia is one of the vibrant sectors in...
May 2011
50 pages
China Health Management Survey Report, 2011
US$ 1,400.00
With the development of Chinese economy, improvement of living standards and intensified aging population, Chinese people have growing demand for health management. In China, many industries are activ...
May 2011
62 pages
Minimally Invasive Surgical Devices, World Market
US$ 3,500.00
Price (Single User PDF): US$ 3,500.00 Price (Global Site License): US$ 7,000.00 Minimally invasive surgery (MIS) allows doctors to perform many complicated operations with a short hospital stay. It i...
May 2011
150 pages
Orthopedic Biomaterials, The World Market
US$ 3,995.00
Price (Single User PDF): US$ 3,995.00 Price (Global Site License): US$ 7,995.00 Orthopedic biomaterial products, which can be organic or synthetic in nature, are implanted into or near a bone fractur...
May 2011
250 pages
Drug Combinations: New Rules, New Opportunities
US$ 895.00
Single symptom. Single illness. Single drug.
For years, drug therapy has been built on that basic equation. Yet as genomic biology sheds light on the astonishing intricacy of disease patholo...
May 2011
48 pages
Keys for Pharma Success: Integrating Social
US$ 595.00
Pharma companies began their journey in social media over four years ago with a single initiative, often a Twitter account. Subsequently, they have embarked upon a process of layering their digital fo...
May 2011
51 pages
Market Access Europe: It's Not Just About Price
US$ 795.00
“May you live in interesting times.” Considered a curse by some, the saying could also be a blessing—especially when it comes to the evolving world of market access in Europe. Given its complex geo-po...
May 2011
71 pages
European Market for Cardiac Rhythm Management, Electrophysiology & Ablation Devices 2011
US$ 11,495.00
... 2010, the European market for cardiac rhythm management, electrophysiology, and ablation devices was valued at over €2.3 billion ($3.09 billion). The fastest ... as Biotronik, Boston Scientific, Medtronic and St. Jude Medical lead the market, among many others. This report provides a comprehensive and detailed ...
May 2011
462 pages
Vitamins and Dietary Supplements in Indonesia
US$ 900.00
Vitamins and dietary supplements continued to record healthy double-digit current retail value growth in 2010, with sales being boosted by the increasing popularity of preventive medicine, especially...
May 2011
44 pages
Medicated Skin Care in Kazakhstan
US$ 990.00
... on high-priced medicines, such as medicated skin care. Changing perceptions of beauty have also made people less... Euromonitor International's Medicated Skin Care in Kazakhstan report offers a comprehensive guide ... and Allergy Remedies, Child-Specific Digestive Remedies, Child-Specific Medicated Skin Care, Cold Sore Treatments, Combination Products - Cough, Cold and Allergy ...
May 2011
24 pages
Acute Coronary Syndrome (ACS) Drug Market Prospects 2011-2021
US$ 2,325.00
... and a research interview (shown in the accompanying lists). Acute Coronary Syndrome (ACS) Drug Market Prospects 2011-2021 shows you revenue ... technologies in development, assessing potential among the R&D product candidates for ACS You will investigate competition and opportunities influencing the industry ...
May 2011
132 pages
